Driving Innovation
The Englander Institute for Precision Medicine (EIPM) is at the forefront of research that precipitates new strategies to treat cancer and other diseases and is poised to usher in a new era of personalized medicine.
In EIPM we collaborate with clinical departments of Weill Cornell Medicine (WCM) and the NewYork-Presbyterian (NYP) to provide a comprehensive interpretation of patient genomes and act as a permanent resource for our clinicians to make effective use of genomic data to optimize patient care.
Our research initiative brings together multitalented and motivated physician-scientists and researchers from around the world that specialize in various different fields including medicine, computational biology, genomics, and biomedicine to target some of the most formidable health challenges.
Together we are channeling our efforts towards developing therapies where genomic data contribute significantly to the clinical result and offer hope for transforming health care.
These innovative research areas include:
Disease-targeting initiatives
Genomics and Computational Analysis
If you want to find out more about our publications, and for more on our institute’s research focus please click: